Cerebral Salt Wasting (CSW)
Cerebral salt wasting is a disorder of excessive renal sodium loss associated with intracranial pathology, leading to hyponatraemia and true hypovolaemia. It most commonly occurs in the context of acute brain injury, subarachnoid haemorrhage, traumatic brain injury, or intracranial infection. Cerebral salt wasting can closely mimic SIADH biochemically, yet requires fundamentally different management. Failure to distinguish between the two can worsen neurological and circulatory instability.
What You Need to Know
Cerebral salt wasting develops when acute brain injury disrupts normal neurohormonal control of sodium and water balance. Injury to the brain alters signalling pathways that regulate renal sodium handling, leading to inappropriate sodium loss in the urine. Because water follows sodium osmotically, ongoing natriuresis is accompanied by obligate water loss, resulting in hypovolaemia alongside hyponatraemia.
This process represents true sodium depletion rather than dilution. As sodium content falls, plasma osmolality decreases, and intravascular volume contracts. The body attempts to compensate through activation of the renin–angiotensin–aldosterone system and sympathetic pathways, but these responses are often overridden by persistent renal sodium wasting driven by central nervous system injury.
Several core physiological features distinguish cerebral salt wasting:
Excessive renal sodium excretion despite falling serum sodium
Progressive intravascular volume depletion
Hyponatraemia caused by sodium loss rather than water excess
Activation of compensatory hormones that fail to correct imbalance
Because both sodium and water are lost together, patients become hypovolaemic rather than euvolaemic. This distinction is critical, as reduced circulating volume impairs cerebral perfusion and can worsen neurological injury. Cerebral salt wasting therefore represents a combined electrolyte and volume disorder driven by brain-mediated renal dysfunction, requiring careful differentiation from other causes of hyponatraemia.
Beyond the Basics
Neurohormonal disruption and natriuresis
Intracranial injury alters communication between the central nervous system and the kidneys, leading to dysregulated sodium handling. Increased release of natriuretic peptides, including brain natriuretic peptide, promotes renal sodium excretion by inhibiting tubular reabsorption in both the proximal nephron and collecting ducts.
Sympathetic input to the kidneys may also be reduced following brain injury, further limiting sodium retention. The combined effect is sustained natriuresis that continues despite falling serum sodium levels and declining intravascular volume.
Sodium loss as the primary event
In cerebral salt wasting, sodium loss occurs first and drives subsequent water loss. As sodium is excreted in the urine, water follows osmotically, leading to contraction of extracellular and intravascular volume. This sequence explains why hypovolaemia develops alongside hyponatraemia.
Volume depletion activates compensatory mechanisms such as the renin–angiotensin–aldosterone system and increased antidiuretic hormone secretion. However, these responses are ineffective because natriuretic signalling continues to override renal sodium conservation, preventing restoration of sodium balance.
Hypovolaemia and cerebral perfusion
Loss of intravascular volume reduces cerebral perfusion pressure, particularly in patients with impaired autoregulation or raised intracranial pressure. Reduced perfusion increases vulnerability to secondary brain injury and may worsen neurological outcomes following the initial insult.
Systemically, hypovolaemia contributes to hypotension and tachycardia. These features may be misattributed to sepsis, haemorrhage, or dehydration if the underlying sodium-wasting process is not identified, delaying appropriate management.
Hyponatraemia and neurological injury
Falling serum sodium lowers extracellular osmolality, driving water into brain cells and contributing to cerebral oedema. In cerebral salt wasting, this occurs in the setting of reduced circulating volume, compounding neurological risk through both osmotic and perfusion-related mechanisms.
Because sodium loss continues, hyponatraemia may worsen despite fluid restriction. This pattern highlights the importance of recognising the underlying pathophysiology rather than responding to laboratory values alone, as inappropriate restriction can exacerbate hypovolaemia and further compromise cerebral perfusion.
Clinical Connections
Cerebral salt wasting commonly presents with hyponatraemia accompanied by inappropriately high urinary sodium loss and clear evidence of intravascular volume depletion. Hypotension, tachycardia, reduced central venous pressure, dry mucous membranes, and negative fluid balance point toward true sodium and water loss rather than dilution. Neurological deterioration in this context arises from the combined effects of worsening hyponatraemia and reduced cerebral perfusion, both of which place vulnerable brain tissue at risk.
Assessment can be challenging in patients with intracranial disease, where changes in consciousness or haemodynamics may have multiple contributors. Features that support cerebral salt wasting rather than dilutional hyponatraemia include:
Falling serum sodium with persistently high urine sodium
Clinical signs of hypovolaemia rather than euvolaemia
Worsening hypotension or tachycardia despite fluid restriction
Neurological decline coinciding with negative fluid balance
Management priorities differ fundamentally from those used in SIADH. Treatment requires replacement of both sodium and intravascular volume, commonly using isotonic saline and, in more severe cases, hypertonic saline. Ongoing losses may necessitate continuous replacement and close biochemical monitoring. Fluid restriction, which is appropriate in SIADH, can worsen hypovolaemia in cerebral salt wasting and further compromise cerebral perfusion.
Understanding the underlying physiology is critical in patients with brain injury, subarachnoid haemorrhage, or neurosurgical conditions where both SIADH and cerebral salt wasting may occur. Careful assessment of volume status, urine studies, and sodium trends guides safe management and helps prevent secondary neurological injury caused by inappropriate treatment strategies.
Concept Check
Why does cerebral salt wasting cause true hypovolaemia rather than dilutional hyponatraemia?
How do natriuretic peptides contribute to renal sodium loss in CSW?
Why is cerebral perfusion particularly vulnerable in cerebral salt wasting?
How does CSW differ physiologically from SIADH despite similar laboratory findings?
Why can fluid restriction worsen outcomes in cerebral salt wasting?